ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,966Medicare Part D Prescriptions Filled, Including Refills

Rank: 693 out of 6645

$495K Total Retail Price of All Prescriptions

Rank: 1179 out of 6645

315 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
99% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 315 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

14% of this provider’s 315 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

2% of this provider’s 9,932 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$45 was the average price of a prescription from this provider, compared to $64 among peers.

Prescriptions per Patient

35 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
FAMOTIDINE 836 757 1 33
DOXAZOSIN MESYLATE 490 473 2 81
LISINOPRIL 365 328 3 3
AMLODIPINE BESYLATE 345 318 4 2
CELEBREX 308 293 5 54
TRIAMCINOLONE ACETONIDE 251 225 6 55
LOVASTATIN 250 228 7 15
METFORMIN HCL 248 231 8 7
LIDODERM 239 236 9 53
GABAPENTIN 234 205 10 18
AMOXICILLIN 211 201 11 107
ISOSORBIDE MONONITRATE ER 200 193 12 66
TAMSULOSIN HCL 190 190 13 22
PANTOPRAZOLE SODIUM 189 178 14 29
METOPROLOL SUCCINATE 185 179 15 24
GLIMEPIRIDE 179 156 16 47
NEXIUM 178 176 17 40
GLIPIZIDE 175 175 18 23
FELODIPINE ER 165 153 19 105
PROAIR HFA 154 154 20 32
ATORVASTATIN CALCIUM 148 146 21 10
HYDROCODONE-ACETAMINOPHEN 136 99 S3 22 5
OMEPRAZOLE 129 112 23 6
DIOVAN 125 125 24 19
TRAMADOL HCL 116 78 25 30
SINGULAIR 112 112 26 76
METOPROLOL TARTRATE 105 78 27 13
IBUPROFEN 93 86 28 42
PROCTOZONE-HC 93 77 28 243
CROMOLYN SODIUM 91 87 30 331
PREDNISONE 89 80 31 57
CLOPIDOGREL 88 81 32 36
QUETIAPINE FUMARATE 87 77 33 101
MECLIZINE HCL 87 54 33 122
ZOLPIDEM TARTRATE 83 75 35 17
DONEPEZIL HCL 80 80 36 27
CLOTRIMAZOLE-BETAMETHASONE 79 66 37 177
LEVOTHYROXINE SODIUM 78 78 38 4
MONTELUKAST SODIUM 74 74 39 128
LANTUS 73 60 40 50
HYDROXYZINE HCL 71 67 R 41 161
PLAVIX 70 68 42 49
NAMENDA 68 68 43 41
BENAZEPRIL HCL 63 36 44 21
AMLODIPINE BESYLATE-BENAZEPRIL 61 61 45 97
LOPERAMIDE 59 56 46 281
AZITHROMYCIN 59 55 46 44
MEGESTROL ACETATE 59 59 R 46 104
CEPHALEXIN 58 51 49 111
ADVAIR DISKUS 58 52 49 45
DIPHENOXYLATE-ATROPINE 57 53 51 214
SIMVASTATIN 56 56 52 1
DILTIAZEM 24HR CD 53 53 53 176
CLONIDINE HCL 52 52 54 56
RANITIDINE HCL 50 28 55 51
METOCLOPRAMIDE HCL 50 50 55 120
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 20, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.